Literature DB >> 30166442

Is GPNMB the Achilles' Heel of Mo-MDSC While Marking Their Suppressive Activity?

Mario P Colombo1.   

Abstract

Glycoprotein nonmetastatic B/DC-Hil/Osteoactivin on myeloid-derived suppressor cells impairs T lymphocytes through the binding of Syndecan-4, delineating a new checkpoint pair to be targeted perhaps in combination with PD-1/PD-L1 blockage.See related article by Kobayashi et al., p. 828. ©2018 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30166442     DOI： 10.1158/1078-0432.CCR-18-2334

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  2 in total

1.  SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.

Authors:  Sabina Sangaletti; Giovanna Talarico; Claudia Chiodoni; Barbara Cappetti; Laura Botti; Paola Portararo; Alessandro Gulino; Francesca Maria Consonni; Antonio Sica; Giovanni Randon; Massimo Di Nicola; Claudio Tripodo; Mario P Colombo
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

2.  Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD.

Authors:  Claire Gérard; Marine Thébault; Baptiste Lamarthée; Coraline Genet; Florine Cattin; Andréa Brazdova; Nona Janikashvili; Claudie Cladière; Marion Ciudad; Séthi Ouandji; Thibault Ghesquière; Hélène Greigert; Claire Tinel; Olivier Adotevi; Philippe Saas; Maxime Samson; Sylvain Audia; Bernard Bonnotte
Journal:  Front Immunol       Date:  2022-03-08       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.